HUSTON JOHN J 4

4 · COLGATE PALMOLIVE CO · Filed Aug 14, 2020

Form 4

Period: 2020-08-12

Vice President

Transactions

Exercise/Conversion
Common Stock
2020-08-12$72.99/sh+38,430$2,805,006→ 82,988 total
Exercise/Conversion
Common Stock
2020-08-12$73.00/sh+24,100$1,759,300→ 107,088 total
Exercise/Conversion
Common Stock
2020-08-12$72.00/sh+22,375$1,611,000→ 129,463 total
Sale
Common Stock
2020-08-12$77.18/sh−84,905$6,553,375→ 44,558 total
Exercise/Conversion
Stock Option (Right to Buy)
2020-08-12−22,375→ 0 total
Exercise: $72.00Exp: 2022-06-16→ Common Stock (22,375 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2020-08-12−38,430→ 0 total
Exercise: $72.99Exp: 2022-09-08→ Common Stock (38,430 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2020-08-12−24,100→ 12,050 total
Exercise: $73.00Exp: 2023-09-25→ Common Stock (24,100 underlying)

Holdings

Footnotes (6)

[F1]Exercise of stock options awarded under the issuer's incentive compensation plan.
[F2]Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
[F3]Weighted average price, as these shares were sold in multiple transactions at prices ranging from $77.00 to $77.43, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]Option became exercisable in equal annual installments over two years beginning on the second anniversary of the June 16, 2016 grant date.
[F5]Option became exercisable in one-third increments beginning on the first anniversary of the September 8, 2016 grant date.
[F6]Option became exercisable in one-third increments beginning on the first anniversary of the September 25, 2017 grant date.

Documents

1 file